Derivation and Validation of a Novel Opioid-Induced Respiratory
Depression Risk Prediction Tool

 

After viewing the webinar, please go to http://www.saxetesting.com/init/ where you may log in and register. 
Once you have completed the test, you may download your certificate.

Continuing Education for Physicians, Nurses, and Respiratory Therapists

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and Saxe Healthcare Communications. SynAptiv is accredited by ACCME for 1 AMA PRA Category 1 Credit™. Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care. This education activity is approved for 1.0 contact hour. Provider Saxe Healthcare Communications approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.

 

Support for this educational activity from Medtronic